Description
The CJC-1295 (No DAC) + Ipamorelin blend is one of the most popular combinations in peptide research. By pairing a GHRH analog with a hexapeptide Ghrelin mimetic, researchers can investigate a multi-faceted approach to growth hormone secretion.
Component Breakdown
-
CJC-1295 (No DAC): A modified form of GHRH (1-29) with “Drug Affinity Complex” removed. It is researched for its ability to increase the amount of GH secreted per pulse.
-
Ipamorelin: A pentapeptide that mimics Ghrelin. It is researched for its ability to initiate the GH pulse with high specificity, avoiding significant spikes in cortisol or prolactin.
The “Synergy” Effect Research suggests that administering these two compounds together may result in a larger release of growth hormone than the sum of their individual effects. This “1+1=3” synergy is the primary focus of most studies involving this blend.
Quality Assurance
-
Ratio: 1:1 Blend (e.g., 5mg CJC + 5mg Ipamorelin)
-
Purity: >99% Combined Purity (HPLC Verified)
-
Form: Sterile White Lyophilized Powder
FOR RESEARCH USE ONLY:
This product is sold strictly as a chemical reference standard for in-vitro laboratory research purposes only. It is not intended for human or animal consumption, injection, or administration of any kind. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Bodily introduction into humans or animals is strictly prohibited. For use by qualified research professionals only.
